374 related articles for article (PubMed ID: 34880444)
1. Invasive fungal infections in neonates: a review.
Weimer KED; Smith PB; Puia-Dumitrescu M; Aleem S
Pediatr Res; 2022 Jan; 91(2):404-412. PubMed ID: 34880444
[TBL] [Abstract][Full Text] [Related]
2. End-organ damage from neonatal invasive fungal infection: a 14-year retrospective study from a tertiary center in China.
Han T; Qiu M; Niu X; Wang S; Wang F; Cao J; Tang S; Cheng L; Mei Y; Liang H; Feng Z; Chen G; Li Q
BMC Infect Dis; 2024 May; 24(1):521. PubMed ID: 38783182
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic, efficacy, and safety considerations for the use of antifungal drugs in the neonatal population.
Scott BL; Hornik CD; Zimmerman K
Expert Opin Drug Metab Toxicol; 2020 Jul; 16(7):605-616. PubMed ID: 32508205
[TBL] [Abstract][Full Text] [Related]
4. Invasive cutaneous mucormycosis in a preterm neonate presenting as a vesicobullous lesion.
Mishra S; Shelly D; Gupta D; Bharadwaj R
Indian J Pathol Microbiol; 2018; 61(1):103-105. PubMed ID: 29567895
[TBL] [Abstract][Full Text] [Related]
5. Management of Invasive Fungal Disease in Neonates and Children.
Ferreras-Antolín L; Sharland M; Warris A
Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S2-S6. PubMed ID: 31205236
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Cleminson J; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003478. PubMed ID: 26497202
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2013 Mar; (3):CD003478. PubMed ID: 23543519
[TBL] [Abstract][Full Text] [Related]
8. ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children.
Warris A; Lehrnbecher T; Roilides E; Castagnola E; Brüggemann RJM; Groll AH
Clin Microbiol Infect; 2019 Sep; 25(9):1096-1113. PubMed ID: 31158517
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial strategies for combating invasive fungal infections.
Spitzer M; Robbins N; Wright GD
Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
[TBL] [Abstract][Full Text] [Related]
10. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.
Gamaletsou MN; Walsh TJ; Sipsas NV
Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Clerihew L; Austin N; McGuire W
Cochrane Database Syst Rev; 2007 Oct; (4):CD003850. PubMed ID: 17943803
[TBL] [Abstract][Full Text] [Related]
12. Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses.
Jacobs SE; Wengenack NL; Walsh TJ
Semin Respir Crit Care Med; 2020 Feb; 41(1):115-130. PubMed ID: 32000288
[TBL] [Abstract][Full Text] [Related]
13. Emerging Issues in Antifungal Resistance.
Perfect JR; Ghannoum M
Infect Dis Clin North Am; 2020 Dec; 34(4):921-943. PubMed ID: 33131575
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Cleminson J; Austin N; McGuire W
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003850. PubMed ID: 26497056
[TBL] [Abstract][Full Text] [Related]
15. Antifungal stewardship considerations for adults and pediatrics.
Hamdy RF; Zaoutis TE; Seo SK
Virulence; 2017 Aug; 8(6):658-672. PubMed ID: 27588344
[TBL] [Abstract][Full Text] [Related]
16. An update on the global treatment of invasive fungal infections.
Munzen ME; Goncalves Garcia AD; Martinez LR
Future Microbiol; 2023 Nov; 18(15):1095-1117. PubMed ID: 37750748
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2009 Oct; (4):CD003478. PubMed ID: 19821309
[TBL] [Abstract][Full Text] [Related]
18. [Recent research on pharmacological prevention strategies for invasive fungal infection in preterm infants].
Huang FJ; Xiong T; Tang J
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1171-1177. PubMed ID: 36305120
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of bacterial sepsis and invasive fungal infection in neonates and infants requiring major surgery: an Italian multicentre prospective study.
Auriti C; De Rose DU; Santisi A; Martini L; Ronchetti MP; Ravà L; Antenucci V; Bernaschi P; Serafini L; Catarzi S; Fiorini P; Betta P; Scuderi MG; Di Benedetto V; Ferrari S; Maino M; Cavigioli F; Cocchi I; Giuffré M; Bonanno E; Tzialla C; Bua J; Pugni L; Della Torre B; Nardella G; Mazzeo D; Manzoni P; Capolupo I; Ciofi Degli Atti M; Dotta A; Stronati M; Raponi M; Mosca F; Bagolan P;
J Hosp Infect; 2022 Dec; 130():122-130. PubMed ID: 36202186
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal infections during the neonatal period: diagnosis, treatment and prophylaxis.
Tezer H; Canpolat FE; Dilmen U
Expert Opin Pharmacother; 2012 Feb; 13(2):193-205. PubMed ID: 22220691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
